UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:March 24,
GeoVax Labs (NASDAQ:GOVX)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more GeoVax Labs Charts.
GeoVax Labs (NASDAQ:GOVX)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more GeoVax Labs Charts.

Geovax Labs, Inc. News

GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine
Thursday 4 April 2024 (1 month ago) • GlobeNewswire Inc.
GeoVax to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine Congress
Thursday 28 March 2024 (1 month ago) • GlobeNewswire Inc.
GeoVax to Present at the 36th Annual Roth Conference
Tuesday 12 March 2024 (2 months ago) • GlobeNewswire Inc.
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Monday 11 March 2024 (2 months ago) • Edgar (US Regulatory)
Form EFFECT - Notice of Effectiveness
Sunday 10 March 2024 (2 months ago) • Edgar (US Regulatory)
GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System
Wednesday 6 March 2024 (2 months ago) • GlobeNewswire Inc.
Form S-3 - Registration statement under Securities Act of 1933
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Thursday 29 February 2024 (2 months ago) • Edgar (US Regulatory)
GeoVax Reports 2023 Year-End Financial Results and Provides Business Update
Thursday 29 February 2024 (2 months ago) • GlobeNewswire Inc.
Form 4 - Statement of changes in beneficial ownership of securities
Thursday 22 February 2024 (2 months ago) • Edgar (US Regulatory)
GeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024
Thursday 22 February 2024 (2 months ago) • GlobeNewswire Inc.
GeoVax to Present at the 2024 BIO CEO & Investor Conference
Monday 19 February 2024 (3 months ago) • GlobeNewswire Inc.

More Geovax Labs, Inc. News Articles